These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Bagattini M, Crivaro V, Di Popolo A, Gentile F, Scarcella A, Triassi M, Villari P, Zarrilli R. J Antimicrob Chemother; 2006 May; 57(5):979-82. PubMed ID: 16531430 [Abstract] [Full Text] [Related]
6. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. Antimicrob Agents Chemother; 2004 Oct; 48(10):3720-8. PubMed ID: 15388426 [Abstract] [Full Text] [Related]
10. [Genotype of TEM- and SHV-type beta-lactamase producing Klebsiella pneumoniae in Guangzhou area]. Zuo B, Liu ZH, Wang HP, Yang YM, Chen JL, Ye HF. Zhonghua Yi Xue Za Zhi; 2006 Nov 07; 86(41):2928-32. PubMed ID: 17288792 [Abstract] [Full Text] [Related]
16. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia. Palasubramaniam S, Muniandy S, Navaratnam P. J Microbiol Immunol Infect; 2009 Apr 07; 42(2):129-33. PubMed ID: 19597644 [Abstract] [Full Text] [Related]
18. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group. J Clin Microbiol; 2007 Jan 07; 45(1):199-205. PubMed ID: 17079502 [Abstract] [Full Text] [Related]